Research programme: asthma therapeutics - Genfit/UCB
Latest Information Update: 12 Feb 2008
At a glance
- Originator Genfit; UCB
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 12 Feb 2008 No development reported - Preclinical for Asthma in USA (unspecified route)
- 02 May 2006 Preclinical trials in Asthma in USA (unspecified route)